31271-90-6Relevant articles and documents
Electrophilic fluorination in the synthesis of new fluoroindoles
Hodson, Harold F.,Madge, David J.,Slawin, Alexandra N. Z.,Widdowson, David A.,Williams, David J.
, p. 1899 - 1906 (1994)
Fluorination of trialkylstannylindoles with caesium fluoroxysulfate on Selectfluor(TM) was investigated for the synthesis of inter-alia 2- and 3- fluoroindoles. Caesium fluoroxysulfate gave good yields of these potentially useful intermediates. Selectfluo
Silaphenylmercuric triflate catalyzed reactions: Synthesis of a solid-supported mercuric salt catalyst
Yamamoto, Hirofumi,Sasaki, Ikuo,Hirai, Yuki,Namba, Kosuke,Imagawa, Hiroshi,Nishizawa, Mugio
, p. 1244 - 1247 (2009)
Let it flow, let it flow: A procedure to generate the first solid-supported mercuric salt, silaphenylmercuric triflate, is described. Silaphenylmercuric triflate showed remarkable catalytic activity for an indole synthesis, furanoyne cyclization, arylyne
A Catalytic Construction of Indoles via Formation of Ruthenium Vinylidene Species from N-Arylynamides
Tayu, Masanori,Watanabe, Ryuta,Isogi, Satoshi,Saito, Nozomi
supporting information, p. 1147 - 1151 (2021/01/04)
Treatment of ynamides with a catalytic amount of TpRuCl(PPh3)2 resulted in the construction of indole scaffolds known as privileged structure motifs. This reaction involved a cascade of 1,2-rearrangement and cyclization carrying out C?C bond formation via a ruthenium vinylidene intermediate, as revealed by a deuterium-labeling experiments. Furthermore, the transformation of multi-functionalized ynamide, derived from a practical drug molecule, showed a high functional group tolerance of this reaction. (Figure presented.).
A Series of 2-((1-Phenyl-1H-imidazol-5-yl)methyl)-1H-indoles as Indoleamine 2,3-Dioxygenase 1 (IDO1) Inhibitors
Zheng, Yong,Stafford, Paul M.,Stover, Kurt R.,Mohan, Darapaneni Chandra,Gupta, Mayuri,Keske, Eric C.,Schiavini, Paolo,Villar, Laura,Wu, Fan,Kreft, Alexander,Thomas, Kiersten,Raaphorst, Elana,Pasangulapati, Jagadeesh P.,Alla, Siva R.,Sharma, Simmi,Mittapalli, Ramana R.,Sagamanova, Irina,Johnson, Shea L.,Reed, Mark A.,Weaver, Donald F.
supporting information, p. 2195 - 2205 (2021/05/31)
Indoleamine 2,3-dioxygenase 1 (IDO1) is a promising therapeutic target in cancer immunotherapy and neurological disease. Thus, searching for highly active inhibitors for use in human cancers is now a focus of widespread research and development efforts. I